Stages:
Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
non-degree interdisciplinary courses
Total Funding: $14M
Total Funding: $4M
Total Funding: $35M
Total Funding: $65M
Total Funding: $150M
Total Funding: $29M
Total Funding: $9M
Total Funding: $820M
Total Funding: $230M
Total Funding: $45M
Total Funding: $200M
Total Funding: $4.8M
Total Funding: $240K
Total Funding: $1.4B
Total Funding: $1.3B
Total Funding:
Total Funding:
Total Funding: $15M
Total Funding: $92M
Total Funding: $430M
Total Funding: $780M
Total Funding: $170M
Total Funding:
Total Funding: $1.5B
Total Funding: $340M
Total Funding: $500K
2012
2012
Dr. Sue Xu is a Managing Partner at Amino Capital and joined the firm in 2012, with investment theme of data moat, network effect and domain agnostic. She has successful investments from inception to unicorn in Generative AI, Consumer, SaaS and Frontier tech. She was founding CEO of CandyHouse and CyteSi, both Stanford lab spin-offs. Since 2012, she has involved with more than 300 investments mostly in seed and Series A, with around 20 unicorns and over 35 companies with valuation higher than $100M, including Chime, Rippling, Grail(acquired by Illumina), Webflow, Weee, DFINITY, Replit, Oasis Labs, OmiseGo, Turing, Wyze, GetAccept, Guesty, Instawork, Wetravel, StarRocks, Karbon Card, Unbabel, and WriteSonic. Dr. Sue Xu began her early stage entrepreneurship when she was the founding scientist of GlycoMira (also involved in undergrad and PhD laboratory spin-offs). She has three patents and over 20 journal publications, and previously was a medical school researcher at Stanford University.
2020
2020
Series A Investor
2018
2018
Seed Round Investor
2017
2017
Seed Round Investor
2017
2017
Seires B Investor
2015
2015
Seed Round Investor
2015
2015
Seed Round Investor
2016
2016
Seed Round Investor
2013
2013
Seed Round Investor
2013
2013
Seed Round Investor